Testing for Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG) in typical MS

被引：1
|
作者：
Lopez-Chiriboga, Sebastian [1 ]
Pittock, Sean J. [1 ,2 ]
Weinshenker, Brian G. [1 ]
Chen, John J. [1 ,3 ]
Flanagan, Eoin [1 ,2 ]
机构：
[1] Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Lab Med & Pathol, 200 1st St SW, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Ophthalmol, 200 1st St SW, Rochester, MN 55905 USA
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2019年 / 35卷
关键词：
D O I：
10.1016/j.msard.2019.06.037
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：34 / 35
页数：2
相关论文
共 50 条
  • [1] Response to correspondence: Testing for myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in typical MS
    Breza, Marianthi
    Koutsis, Georgios
    Tzartos, John S.
    Velonakis, Georgios
    Evangelopoulos, Maria Eleftheria
    Tzanetakos, Dimitrios
    Karagiorgou, Katerina
    Angelopoulou, Georgia
    Kasselimis, Dimitrios
    Potagas, Constantin
    Anagnostouli, Maria
    Stefanis, Leonidas
    Kilidireas, Constantinos
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 : 156 - 157
  • [2] Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Perineuritis
    Lopez-Chiriboga, A. Sebastian
    Van Stavern, Gregory
    Flanagan, Eoin P.
    Pittock, Sean J.
    Fryer, Jim
    Bhatti, M. Tariq
    Chen, John J.
    NEURO-OPHTHALMOLOGY, 2020, 44 (01) : 1 - 4
  • [3] Long term outcomes in myelin oligodendrocyte glycoprotein-IgG (MOG-IgG) associated disorders
    Lopez-Chiriboga, A. S.
    Buciuc, M.
    Sechi, E.
    Pittock, S. J.
    Chen, J. J.
    Weinshenker, B. G.
    Dubey, D.
    Amy, K.
    Tillema, J. -M.
    Flanagan, E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 366 - 366
  • [4] Long term outcomes in Myelin Oligodendrocyte Glycoprotein-IgG (MOG-IgG) Associated Disorders
    Lopez-Chiriboga, Sebastian
    Buciuc, Marina
    Sechi, Elia
    Pittock, Sean
    Chen, John
    Weinshenker, Brian
    Dubey, Divyanshu
    Kunchok, Amy
    Tillema, Jan-Mendelt
    Flanagan, Eoin
    NEUROLOGY, 2020, 94 (15)
  • [5] Cross-reactivity of MOG-IgG against Butyrophilins in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
    Nishiyama, Shuhei
    Mikami, Takahisa
    Bilodeau, Phillippe-Antoine
    Anderson, Monique
    Bobrowski-Khoury, Natasha
    Drosu, Natalia
    Levy, Michael
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 239 - 239
  • [6] Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease and MOG Testing Landscape in Canada
    Burton, Jodie
    Youn, Saerom
    Al-Ani, Abdullah
    Costello, Fiona
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 409 - 410
  • [7] Anti-aquaporin-4 antibody (AQP4-IgG) and anti-myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in the cerebrospinal fluid
    Akaishi, Tetsuya
    Misu, Tatsuro
    NEURAL REGENERATION RESEARCH, 2024, 19 (05) : 949 - 950
  • [8] Anti-aquaporin-4 antibody(AQP4-IgG) and anti-myelin oligodendrocyte glycoprotein antibody(MOG-IgG) in the cerebrospinal fluid
    Tetsuya Akaishi
    Tatsuro Misu
    Neural Regeneration Research, 2024, 19 (05) : 949 - 950
  • [9] Patterns and utility of myelin oligodendrocyte glycoprotein (MOG) antibody testing in cerebrospinal fluid
    Burton, Jodie M.
    Youn, Saerom
    Al-Ani, Abdullah
    Costello, Fiona
    JOURNAL OF NEUROLOGY, 2024, 271 (05) : 2182 - 2194
  • [10] A retrospective investigation of MOG-IgG titers in relapse and disability prediction in adult and pediatric myelin oligodendrocyte glycoprotein antibody-associated disease patients
    McDonald, J.
    Santoro, J. D.
    Sattarnezhad, N.
    Tomczak, A.
    Sumera, J.
    Van Haren, K.
    Corwin, N.
    Kipp, L.
    Lock, C.
    Dunn, J.
    Hinman, J.
    Nelson, L.
    Han, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 427 - 428
12345